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DOES THE DEGREE OF LUM1N.U N OWING OF SEGMENTS FREE 
OF USTF,NOSlS 4 TO 12 MONTHS AFTFJ ANGIOPLASn PREDICT 
iONG IERM OUTCOME? 
Hi&am A. Ba’albaki, Wiiam S. Weintraub, Ziyad M.B. Gb& John S. 
Douglas, Jr, Carya L Cohen, Henry Libennan, Dou& C. MO* Spenctr B. 
King III. Division of Cardiology, Emory University school of Medicine, Atlanta 
GA 
While cardiac events continue lo occur in in patients @Is) free of an&graphic 
restenosis after PTCA, it is not known whether late events are dependent on the 
remaining disease in previously dilated segments (D-site) or the extent of 
disea.. elsewhere in the coroq arteries (ND-site). The puqose of this study 
was to determine whether narrowing at D-site(s) and/or ND-site(s) present on 
an&graphic follow-up in pts whose D-site had <SO% diameter narrowing 4 to 
12 months after PTCA correiates with late outcome. 1502 such pts were 
identified: 79% with 1 vessel disease, ejection fraction 59212%. 
Revascularization was complete in 84% (99% for 1 vessel disease). Time to 
angiographic restudy documenting patency was 6.8+1.6 monlbs. Cliid 
follow-up at 40+21 months was available in 1489 pts(99%). Pts were grouped 
according to 96 narrowing of ND-site(s) (none, <SO%, > =SO%) and of D- 
site(s) (e30%, 31%.49%) on angiographic restudy. Multivariate correlates of 6 
war freedom from events (MI, PTCA, CABG, death): hypertension (1 
diabetes (p=O.oOl), and %-narrowing in ND-sites (p<O.~l). 
I Freedom p value 
p = O.oQb), 
Conclusions: 1) In the absence of angiographically significant restenosis, the % 
narrowing is not an independent predictor of late outcome. 2) Late outcome in 
these pcs is strongly dependent on the severity of disease elsewhere in non- 
dilated segments. 
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From a number of smaller studier diabetes (DM) appears 10 be an impor- 
tant risk factor for restenosis after PTCA. Few data are available with regard 
10 type of DM and restenosLs or the clinical presentation of resaenosis in DM. 
To determine the relationshi between DM and resteaosis we evaluated 960 
randomly selected patients Iks ) under 
follow.up was obtained in Li % (n P 7 4 
oing firs t ime PTck Angiographic 
9) of P’TS eligible by protocol at a 
median of 185 days. This population included 124 diabetics (17%) who were 
subdivided inro insulin treated (INSULIN) II = 
treated (ORAL) (a = 56) and diet treated (Dl b 
33), oral hypoglycemic 
(n = 35) groups. Diabetics 
were less likely to have a history of hyperlipidemia or smoking and were more 
likely 10 be hypertensive. No differences in other baseline characlerisrics were 
nored. R&ten&s rates (RR) are shown below: 
GE) 95% Conf Int f% 
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DU 124 it msutm 
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It w8f also noted 
%% 
tieau presenring with 
1. 
that there was no difference in the 
asymptomatic restenosis in DM vs non 
‘I&se results reinforce that diabetes is a major risk factor for r&stenosis. 
The lack of an increased rate of asymptomatic restenosis in diabetes is 
su 
hi 8 
rising and further confuses Ihe issue of silent ischemia in diabetes. The 
er incidence OC restenwis in pharmacologically treated (INSULIN or 
ORAL) diabetics (p = c 0.005) suggests potential role5 for mote severe 
diabetes or insulin in resteaosis. 
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ANGIOTENSIW CONWERTfpEc IBITION 
RESTENOSIS IN EXPERI AL ANfXOPLASTT. 
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Angiotensin converting enzyme inhibition (ACEI) 
prevents myointimal proliferation after injury of t 2 
rat carotid artery. To determine whether trlis treatment 
also reduces restenosis (RS) after angioplasty (A) in a 
model of atherosclerosis, we gave cilazapril 5 mg/kg/day 
in food to 9 hypercholesterolemic rabbits with stenotic 
lesions in the iliac artery, starting 1 week (W) prior 
to iliac A and continuing until final angiography at 4 
W. Treated animals bixd cilazapril levels of 62 + 52 
rig/ml, ACE activity of 1.79 + 2.99 U/L and systolic 
blood pressure fell by 49.8 T 23 mm Hg. Compared to 
nine controls (C) matched fo? similar pre and post-A 
lesion diameters, angiographic data showed: 
Pre A 
Luminal Diameter (mm, mean + S.D.) 
Post A 4 w Post A Difference 
ACBI 0.8m22 1.24 +0.30 0.96 +0.20 -0.27 +0.38 
C 0.81 50.29 1.38 TO.19 0.49 To.49 -0.89 TO.51 
P* NS- NS- 0.019 o.oio 
When RS is definer.? as loss of > 50% of the initial 
post A gain, ACE1 decreased the iiicidence of RS (219 
ACE1 vs 819 C, ~~0.018). Histologically, the treated and 
ur.rc?ated animals were qualitatively indistinguishable. 
.n ?e data indicate that ACE1 begun prior to A sig- 
.e I* *. .,2tly reduces the rate of RS in a hypercholesterol- 
emit, atherosclerotic model of balloon A. The mechanisms 
underlying this effect are unknown. One might speculate 
that a reduction in angiotensin II may result in a de- 
crease in the expression of proto-oncogenes and stimula- 
tion of smooth muscle cell protein production and 
hypertrophy. 
